| Cover | Apr. 11, 2024 |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Apr. 11, 2024 |
| Entity File Number | 001-41245 |
| Entity Registrant Name | Conduit Pharmaceuticals Inc. |
| Entity Central Index Key | 0001896212 |
| Entity Tax Identification Number | 87-3272543 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 4995 Murphy Canyon Road |
| Entity Address, Address Line Two | Suite 300 |
| Entity Address, City or Town | San Diego |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 92123 |
| City Area Code | (760) |
| Local Phone Number | 471-8536 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
| Common Stock, $0.0001 par value per share | |
| Title of 12(b) Security | Common Stock, $0.0001 par value per share |
| Trading Symbol | CDT |
| Security Exchange Name | NASDAQ |
| Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 | |
| Title of 12(b) Security | Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 |
| Trading Symbol | CDTTW |
| Security Exchange Name | NASDAQ |
